Provided is a heterocyclic compound of Chemical Formula 1: ##STR00001##
and an organic light emitting device including the same.

The present invention concerns compounds of Formula (1), pharmaceutically acceptable salts, solvates or prodrugs thereof, pharmaceutical compositions comprising the same, and the use of the same in treating or preventing a disease.

##STR00001##

The present invention concerns compounds of Formula (1), pharmaceutically acceptable salts, solvates or prodrugs thereof, pharmaceutical compositions comprising the same, and the use of the same in treating or preventing a disease.

##STR00001##

Provided is a hetero-cyclic compound of Chemical Formula 1: ##STR00001##
and an organic light emitting device comprising the same.

Provided are a compound capable of improving the luminous efficiency, stability and lifespan of an organic electronic device, an organic electronic element using the same, and an electronic device thereof.

Provided are a compound capable of improving the luminous efficiency, stability and lifespan of an organic electronic device, an organic electronic element using the same, and an electronic device thereof.

An amine-based compound is represented by Formula 1. A light-emitting device includes a first electrode, a second electrode, an interlayer between the first electrode and the second electrode and including an emission layer, and the amine-based compound. An electronic apparatus includes the light-emitting device:

##STR00001##

Formula 1 may be understood by referring to the description of Formula 1 provided herein.

An amine-based compound is represented by Formula 1. A light-emitting device includes a first electrode, a second electrode, an interlayer between the first electrode and the second electrode and including an emission layer, and the amine-based compound. An electronic apparatus includes the light-emitting device:

##STR00001##

Formula 1 may be understood by referring to the description of Formula 1 provided herein.

The present invention provides a tricyclic compound, its preparation method and medical use. The tricyclic compound is a compound having the structure of the following formula (I), and its pharmaceutically acceptable salt, prodrug, tautomer, stereoisomers or mixtures of stereoisomers. The compound of the present invention has significant activity of antagonizing histamine H1 receptor, and has lower anti-M-choline side effects and lower hERG toxicity,

##STR00001##

Wherein the group is defined as described in the specification.

The present invention provides a tricyclic compound, its preparation method and medical use. The tricyclic compound is a compound having the structure of the following formula (I), and its pharmaceutically acceptable salt, prodrug, tautomer, stereoisomers or mixtures of stereoisomers. The compound of the present invention has significant activity of antagonizing histamine H1 receptor, and has lower anti-M-choline side effects and lower hERG toxicity,

##STR00001##

Wherein the group is defined as described in the specification.